Joshua Yang

Biotechnology Entrepreneur

Current
 · Forbes 30 Under 30 Healthcare
 · Co-founder and CEO of Glyphic Biotechnologies, a Seed-stage platform biotech startup
 · Co-founder of Nephrosant, a Series A-stage diagnostics biotech startup

Education
 · MBA @ Stanford Graduate School of Business
 · MD-PhD candidate @ Johns Hopkins University School of Medicine and Department of Biomedical Engineering
 · M.Eng. in Translational Medicine @ UC San Francisco and UC Berkeley
 · B.S. in Bioengineering: Biotechnology and B.S. in General Biology @ UC San Diego

Links
 · Email: me@joshuayang.com
 · Professional Profile: LinkedIn
 · Academic Publications: Google Scholar
 · Curriculum Vitae: PDF
· Twitter: @joshuayoungyang

Recent News

April 2021
 · I was listed on the 2021 Best & Brightest MBAs list by Poets & Quants.

December 2020
 · I was named as a Forbes 30 Under 30 on their 2021 Healthcare list.
 · I was awarded a grant by the Roddenbury Foundation from their Catalyst Fund to validate Cerviscope's cervical cancer screening technology.

September 2020
 · I was selected as a Siebel Scholar Class of 2021, an honor recognizing the most talented students at the world’s leading graduate schools of business, computer science, bioengineering, and energy science.
 · I was interviewed by ProFellow about my experiences winning a fellowship to conduct research in Madrid at the Spanish National Cancer Research Center (CNIO).

Older News

June 2020
 · My team and I won 1st place at the Merck Innovation Cup 2020 for our proposal for a novel drug discovery platform, having been selected out of over 2,000 applicants.
 · My perspective piece titled, A Pandemic of Loneliness, was published in Doximity's Op-Med.
 · My article on how to find fellowships and scholarships for graduate school was published by Sallie Mae on their Within Reach blog.

April 2020
 · Our global health project Cerviscope won 2nd place at the Johns Hopkins Healthcare Design Competition and was a finalist for the Bisciotti Student Entrepreneurship Award

March 2020
 · My first-author publication on Nephrosant's QSant Assay was published in Science Translational Medicine
 · My startup Nephrosant and I were featured in GenomeWeb about the upcoming launch of our QSant assay.
 · I was featured in Poets & Quants 'Meet Stanford GSB's MBA Class of 2021'